BDKRB2 anticorps (C-Term)
Aperçu rapide pour BDKRB2 anticorps (C-Term) (ABIN2209751)
Antigène
Voir toutes BDKRB2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- BDKRB2 (BDKRB2, BK-2 Receptor, Bradykinin Type-2 Receptor, B2R, Bradykinin B2 Receptor, BRB2, BK-2R, BK-2Rs, BK2, B2 Bradykinin Receptor, B2bkr, BK-2, BKR2, Bradykinin Receptor B2)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to 18aa from the C-terminus of human BDKRB2/BK-2. Species sequence homology: monkey.
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
-
Autre désignation
- BDKRB2
-
UniProt
- P30411
-
Pathways
- ACE Inhibitor Pathway, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-